Chemistry:SL-164
From HandWiki
SL-164, also known as dicloqualone or DCQ, is an analogue of methaqualone developed in the late 1960s by a team at Sumitomo.[1] SL-164 has similar sedative, hypnotic[2] and properties to the parent compound, but was never marketed for clinical use, due to higher risk of convulsions. Like other 4-substituted analogues, such as methylmethaqualone, SL-164 may cause seizures.[3]
References
- ↑ "Compositions And Methods For Tranquilizing With Substituted 3-Phenyl-4-Quinazolinone Derivatives" US patent 3651230
- ↑ "Pharmacological studies on 2-methyl-3(2'-methyl-4'-chlorophenyl)-5-chloro-4[H)-quinazolinone (SL-164)". Arzneimittel-Forschung 19 (12): 1945–9. December 1969. PMID 4985336.
- ↑ "[Substituted 4-Quinazolinone Derivatives As Hypnotics]" (in German). Arzneimittel-Forschung 13: 688–701. August 1963. PMID 14085923.
| Alcohols | |
|---|---|
| Barbiturates |
|
| Benzodiazepines |
|
| Carbamates | |
| Flavonoids | |
| Imidazoles | |
| Kava constituents | |
| Monoureides | |
| Neuroactive steroids |
|
| Nonbenzodiazepines | |
| Phenols | |
| Piperidinediones | |
| Pyrazolopyridines | |
| Quinazolinones | |
| Volatiles/gases |
|
| Others/unsorted |
|
0.00 ![]() ![]() ![]() ![]() (0 votes) |
